XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 166 filers reported holding XENON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $99,836,741 | +77.3% | 2,560,573 | +95.8% | 3.13% | +72.6% |
| Q1 2024 | $56,309,874 | -25.8% | 1,308,011 | -20.6% | 1.82% | -34.9% |
| Q4 2023 | $75,875,145 | +5.6% | 1,647,311 | -21.7% | 2.79% | +22.7% |
| Q3 2023 | $71,852,007 | +2.1% | 2,103,396 | +15.0% | 2.27% | -1.3% |
| Q2 2023 | $70,391,591 | -8.0% | 1,828,353 | -14.4% | 2.30% | -8.8% |
| Q1 2023 | $76,487,167 | +25.3% | 2,137,110 | +38.0% | 2.52% | +23.3% |
| Q4 2022 | $61,041,977 | – | 1,548,110 | – | 2.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,516,851 | $44,101,000 | 2.72% |
| Parkman Healthcare Partners LLC | 590,267 | $7,402,000 | 2.08% |
| ACUTA CAPITAL PARTNERS, LLC | 517,500 | $6,489,000 | 1.88% |
| Soleus Capital Management, L.P. | 250,897 | $3,146,000 | 1.79% |
| DAFNA Capital Management LLC | 346,535 | $4,346,000 | 1.25% |
| KNOTT DAVID M | 169,000 | $2,119,000 | 1.16% |
| Ghost Tree Capital, LLC | 325,000 | $4,076,000 | 1.08% |
| Avoro Capital Advisors LLC | 2,800,000 | $35,112,000 | 0.69% |
| NEA Management Company, LLC | 992,107 | $12,441,000 | 0.50% |
| Orbimed Advisors | 2,497,917 | $31,324,000 | 0.44% |